| HSP90B1 |
HSP90B1, TRA1: Endoplasmin precursor |
CSNK2B |
CSNK2B, CK2N, G5A: Casein kinase II subunit beta |
1.517 |
Evidence |
|
| PSMD12 |
PSMD12: 26S proteasome non-ATPase regulatory subunit 12 |
THOC1 |
THOC1, HPR1: THO complex subunit 1 |
1.515 |
Evidence |
|
| PSMD12 |
PSMD12: 26S proteasome non-ATPase regulatory subunit 12 |
IRAK1 |
IRAK1, IRAK: Interleukin-1 receptor-associated kinase 1 |
1.515 |
Evidence |
|
| HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
ZNF629 |
ZNF629, KIAA0326, ZNF65: Zinc finger protein 629 |
1.512 |
Evidence |
|
| ACTB |
ACTG1, ACTB, ACTG: Actin, cytoplasmic 2 |
CNN3 |
CNN3: Calponin-3 |
1.512 |
Evidence |
|
| CIC |
CIC, KIAA0306: Protein capicua homolog |
SERPINB13 |
SERPINB13, PI13: Serpin B13 |
1.51 |
Evidence |
|
| PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
CKAP1 |
TBCB, CG22, CKAP1: Tubulin folding cofactor B |
1.51 |
Evidence |
|
| ZBTB16 |
ZBTB16, PLZF, ZNF145: Zinc finger and BTB domain-containing protein 16 |
TAL1 |
TAL1, SCL, TCL5: T-cell acute lymphocytic leukemia protein 1 |
1.51 |
Evidence |
|
| ACTR3 |
ACTR3, ARP3: Actin-related protein 3 |
CTNND1 |
|
1.51 |
Evidence |
|
| INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
PTPN11 |
IPI00298347 |
1.51 |
Evidence |
|
| BRCA2 |
BRCA2, FACD, FANCD1: Breast cancer type 2 susceptibility protein |
CTTN |
CTTN, EMS1: Src substrate cortactin |
1.51 |
Evidence |
|
| GRIA2 |
IPI00219216 |
PTGIR |
PTGIR, PRIPR: Prostacyclin receptor |
1.51 |
Evidence |
|
| RGS2 |
RGS2, G0S8: Regulator of G-protein signaling 2 |
RGS4 |
RGS4: Regulator of G-protein signaling 4 |
1.51 |
Evidence |
|
| IRS1 |
IRS1: Insulin receptor substrate 1 |
HSP90AA1 |
Hsp89-alpha-delta-N |
1.51 |
Evidence |
|
| SDC4 |
SDC4: Syndecan-4 precursor |
LTB4R |
LTB4R, BLT, BLT1, BLTR, CMKRL1, GPR16, P2RY7: Leukotriene B4 receptor 1 |
1.51 |
Evidence |
|
| NPR2 |
NPR2, ANPRB: Atrial natriuretic peptide receptor B precursor |
LTB4R |
LTB4R, BLT, BLT1, BLTR, CMKRL1, GPR16, P2RY7: Leukotriene B4 receptor 1 |
1.51 |
Evidence |
|
| SDC1 |
SDC1, SDC: Syndecan-1 precursor |
LTB4R |
LTB4R, BLT, BLT1, BLTR, CMKRL1, GPR16, P2RY7: Leukotriene B4 receptor 1 |
1.51 |
Evidence |
|
| ETS1 |
ETS1, EWSR2: Protein C-ets-1 |
DUSP3 |
DUSP3, VHR: Dual specificity protein phosphatase 3 |
1.51 |
Evidence |
|
| CCL5 |
CCL5, D17S136E, SCYA5: Small-inducible cytokine A5 precursor |
CCL11 |
CCL11, SCYA11: Eotaxin precursor |
1.51 |
Evidence |
|
| RNASE1 |
RNASE1, RIB1, RNS1: Ribonuclease pancreatic precursor |
SERPINA10 |
SERPINA10, ZPI, UNQ707/PRO1358: Protein Z-dependent protease inhibitor precursor |
1.51 |
Evidence |
|
| SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
SERPINI1 |
SERPINI1, PI12: Neuroserpin precursor |
1.51 |
Evidence |
|
| SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
PLA2G7 |
PAFAH, PLA2G7: Platelet-activating factor acetylhydrolase precursor |
1.51 |
Evidence |
|
| S100B |
S100B: Protein S100-B |
HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
1.51 |
Evidence |
|
| CD3D |
CD3D, T3D: T-cell surface glycoprotein CD3 delta chain precursor |
BTC |
BTC: Probetacellulin precursor [Contains: Betacellulin |
1.51 |
Evidence |
|
| ESR1 |
ESR1, ESR, NR3A1: Estrogen receptor |
POLR2A |
POLR2A: Uncharacterized protein POLR2A |
1.51 |
Evidence |
|